04Apr 2025
BRD9 Inhibition Promotes Differentiation and Apoptosis in TGCT

BRD9 Inhibition Promotes Differentiation and Apoptosis in TGCT

The study analyzed BRD9 expression in TGCT tissues and cell lines, revealing its heterogeneous presence. BRD9 inhibition reduced cell viability, induced apoptosis, and caused G1-phase arrest. Transcriptomic analysis showed pluripotency loss and epithelial differentiation. These findings suggest BRD9 as a potential therapeutic target for cisplatin-resistant TGCT, providing hope for improved treatment options.

  • #urology

Like

Save

Share